pyrrolidine dithiocarbamate has been researched along with clioquinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Cui, QC; Daniel, KG; Dou, QP; Miller, FR; Orlu, S | 1 |
| Chen, D; Daniel, KG; Dou, QP; Yan, B | 1 |
1 review(s) available for pyrrolidine dithiocarbamate and clioquinol
| Article | Year |
|---|---|
Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer.
Topics: Antineoplastic Agents; Apoptosis; Clioquinol; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Oxyquinoline; Protease Inhibitors; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2007 |
1 other study(ies) available for pyrrolidine dithiocarbamate and clioquinol
| Article | Year |
|---|---|
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
Topics: Anti-Infective Agents, Local; Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clioquinol; Copper; Drug Interactions; Female; Humans; Precancerous Conditions; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2005 |